- Home
- VIAV vs SWTX Comparison
VIAV vs SWTX Comparison
Compare VIAV & SWTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VIAV
- SWTX
- Stock Information
- Founded
- VIAV 1923
- SWTX 2017
- Country
- VIAV United States
- SWTX United States
- Employees
- VIAV N/A
- SWTX N/A
- Industry
- VIAV Semiconductors
- SWTX Biotechnology: Pharmaceutical Preparations
- Sector
- VIAV Technology
- SWTX Health Care
- Exchange
- VIAV Nasdaq
- SWTX Nasdaq
- Market Cap
- VIAV 2.2B
- SWTX 2.2B
- IPO Year
- VIAV 1993
- SWTX 2019
- Fundamental
- Price
- VIAV $9.90
- SWTX $36.30
- Analyst Decision
- VIAV Buy
- SWTX Strong Buy
- Analyst Count
- VIAV 9
- SWTX 6
- Target Price
- VIAV $11.16
- SWTX $64.50
- AVG Volume (30 Days)
- VIAV 2.0M
- SWTX 1.3M
- Earning Date
- VIAV 10-31-2024
- SWTX 11-12-2024
- Dividend Yield
- VIAV N/A
- SWTX N/A
- EPS Growth
- VIAV N/A
- SWTX N/A
- EPS
- VIAV N/A
- SWTX N/A
- Revenue
- VIAV $990,700,000.00
- SWTX $135,487,000.00
- Revenue This Year
- VIAV $4.76
- SWTX $3,498.68
- Revenue Next Year
- VIAV $6.97
- SWTX $98.08
- P/E Ratio
- VIAV N/A
- SWTX N/A
- Revenue Growth
- VIAV N/A
- SWTX N/A
- 52 Week Low
- VIAV $6.60
- SWTX $20.19
- 52 Week High
- VIAV $11.32
- SWTX $53.92
- Technical
- Relative Strength Index (RSI)
- VIAV 54.81
- SWTX 60.70
- Support Level
- VIAV $9.48
- SWTX $34.29
- Resistance Level
- VIAV $10.72
- SWTX $38.58
- Average True Range (ATR)
- VIAV 0.30
- SWTX 2.28
- MACD
- VIAV -0.07
- SWTX 0.55
- Stochastic Oscillator
- VIAV 33.87
- SWTX 74.81
About VIAV Viavi Solutions Inc.
Viavi Solutions Inc. is a global provider of network test, monitoring and assurance solutions to communications service providers, enterprises, network equipment manufacturers, civil government, military and avionics customers. The company also offers high-performance thin-film optical coatings, providing light management solutions to anti-counterfeiting, 3D sensing, electronics, automotive, defense and instrumentation markets. Its operating segments include Network Enablement, Service Enablement, and Optical Security and Performance Products. Geographically, it derives a majority of revenue from the United States.
About SWTX SpringWorks Therapeutics Inc.
SpringWorks Therapeutics Inc is a clinical stage biopharmaceutical company applying a precision medicine approach to acquiring, developing and commercializing life-changing medicines for underserved patient populations suffering from devastating rare diseases and cancer. The company has a differentiated portfolio of small molecule targeted oncology product candidates and is advancing two potentially registrational clinical trials in rare tumor types, as well as several other programs addressing highly prevalent, genetically defined cancers.